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Introduction: Primary central nervous system lymphoma (PCNSL) is a rare entity typically treated 
with a combination of chemotherapy and radiation. The role of surgery is controversial, and biopsy 
may be non-definitive or injurious. We review our series of stereotactic and excisional biopsy as well 
as surgical debulking of PCNSL to quantify overall risk and benefits. 
Methods: Patients with biopsy-confirmed intracranial PCNSL were identified from a large single-
center academic institution between 2012-2018. Preoperative factors and perioperative outcomes 
were retrospectively reviewed. 
Results: A total of 61 cases of PCNSL were identified. Most patients presented with confusion 
(23.0%), weakness/paralysis (19.7%), and gait disturbance (18.0%). 1.6% were incidentally 
identified. HIV status was positive in 8.2% of cases. CSF cytology was positive for malignancy in 
33.3% of applicable cases. Of all procedures, 44.3% were needle biopsy, 27.9% were open 
excisional biopsies, and 27.9% were surgical debulking procedures. Prior biopsy had been 
performed in 9.8%, of which 83.3% (5/6) were positive for PCNSL. Intraoperative frozen pathology 
failed to illicit a definitive diagnosis in 39.3% of cases despite adequate sampling. Stereotactic 
biopsies did not demonstrate an increased risk of non-diagnostic frozen pathology compared to open 
excisional biopsy. Intraoperative complications, 30-day mortality, and long-term survival was not 
associated with open vs. stereotactic biopsy. 
Discussion: Biopsy of PCNSL carries a moderate surgical risk that should not be discounted, 
particularly in the setting of previously diagnosed PCNSL or with evidence of malignancy in CSF 
cytology. Early initiation of chemotherapy continues to be the mainstay of long-term response and 
control. 
 
